D-Deprenyl
Overview[edit | edit source]
D-Deprenyl, also known as selegiline, is a monoamine oxidase inhibitor (MAOI) that is primarily used in the treatment of Parkinson's disease and major depressive disorder. It is a selective inhibitor of monoamine oxidase B (MAO-B) at lower doses, which makes it useful in increasing dopamine levels in the brain.
Mechanism of Action[edit | edit source]
D-Deprenyl works by inhibiting the activity of the enzyme monoamine oxidase B, which is responsible for the breakdown of dopamine in the brain. By inhibiting this enzyme, D-Deprenyl increases the availability of dopamine, which is beneficial in conditions like Parkinson's disease where dopamine levels are reduced.
Clinical Uses[edit | edit source]
D-Deprenyl is primarily used in the management of Parkinson's disease. It is often used as an adjunct therapy to levodopa/carbidopa treatment. In addition to its use in Parkinson's disease, D-Deprenyl is also used in the treatment of major depressive disorder, particularly in patients who do not respond to other treatments.
Side Effects[edit | edit source]
Common side effects of D-Deprenyl include nausea, dizziness, insomnia, and orthostatic hypotension. At higher doses, it can lose its selectivity for MAO-B and inhibit monoamine oxidase A (MAO-A) as well, which can lead to more severe side effects and dietary restrictions due to the risk of hypertensive crisis.
Pharmacokinetics[edit | edit source]
D-Deprenyl is well absorbed from the gastrointestinal tract and is metabolized in the liver. It has a relatively long half-life, which allows for once-daily dosing in most patients. The metabolites of D-Deprenyl include amphetamine and methamphetamine, which can contribute to its stimulating effects.
History[edit | edit source]
D-Deprenyl was first synthesized in the 1960s and was initially investigated for its potential as an antidepressant. Its ability to selectively inhibit MAO-B was discovered later, leading to its use in the treatment of Parkinson's disease.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
